 | • レポートコード：QY2207E09290 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の脳卒中治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脳卒中治療の世界市場のxxx％を占める「静脈注射」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「虚血性脳卒中」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の脳卒中治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの脳卒中治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの脳卒中治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 脳卒中治療のグローバル主要メーカーには、Abbott Laboratories、Cordis、Boston Scientific、Siemens、Genentech、Koninklijke Philips、Medtronic、GE Healthcare、Stryker、Merck、Zocere, Inc.、Acticor Biotech、DiaMedica Therapeutics、Lumosa Therapeutics、AXONIS Therapeutics , Inc.、NovaGo Therapeuticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 脳卒中治療市場は、種類と用途によって区分されます。世界の脳卒中治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 静脈注射、経口剤、その他 【用途別セグメント】 虚血性脳卒中、出血性脳卒中、一過性脳虚血発作 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 脳卒中治療製品概要 - 種類別市場（静脈注射、経口剤、その他） - 用途別市場（虚血性脳卒中、出血性脳卒中、一過性脳虚血発作） - 調査の目的 ・エグゼクティブサマリー - 世界の脳卒中治療販売量予測2017-2028 - 世界の脳卒中治療売上予測2017-2028 - 脳卒中治療の地域別販売量 - 脳卒中治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別脳卒中治療販売量 - 主要メーカー別脳卒中治療売上 - 主要メーカー別脳卒中治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（静脈注射、経口剤、その他） - 脳卒中治療の種類別販売量 - 脳卒中治療の種類別売上 - 脳卒中治療の種類別価格 ・用途別市場規模（虚血性脳卒中、出血性脳卒中、一過性脳虚血発作） - 脳卒中治療の用途別販売量 - 脳卒中治療の用途別売上 - 脳卒中治療の用途別価格 ・北米市場 - 北米の脳卒中治療市場規模（種類別、用途別） - 主要国別の脳卒中治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの脳卒中治療市場規模（種類別、用途別） - 主要国別の脳卒中治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の脳卒中治療市場規模（種類別、用途別） - 主要国別の脳卒中治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の脳卒中治療市場規模（種類別、用途別） - 主要国別の脳卒中治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの脳卒中治療市場規模（種類別、用途別） - 主要国別の脳卒中治療市場規模（トルコ、サウジアラビア） ・企業情報 Abbott Laboratories、Cordis、Boston Scientific、Siemens、Genentech、Koninklijke Philips、Medtronic、GE Healthcare、Stryker、Merck、Zocere, Inc.、Acticor Biotech、DiaMedica Therapeutics、Lumosa Therapeutics、AXONIS Therapeutics , Inc.、NovaGo Therapeutics ・産業チェーン及び販売チャネル分析 - 脳卒中治療の産業チェーン分析 - 脳卒中治療の原材料 - 脳卒中治療の生産プロセス - 脳卒中治療の販売及びマーケティング - 脳卒中治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 脳卒中治療の産業動向 - 脳卒中治療のマーケットドライバー - 脳卒中治療の課題 - 脳卒中治療の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Stroke Therapeutics Market
The global Stroke Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Intravenous Injection accounting for % of the Stroke Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Ischemic Stroke segment is altered to an % CAGR throughout this forecast period.
China Stroke Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Stroke Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Stroke Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stroke Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stroke Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stroke Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stroke Therapeutics market.
Global Stroke Therapeutics Scope and Market Size
Stroke Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Stroke Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Intravenous Injection
Oral
Others
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Company
Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
Merck
Zocere, Inc.
Acticor Biotech
DiaMedica Therapeutics
Lumosa Therapeutics
AXONIS Therapeutics , Inc.
NovaGo Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intravenous Injection
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Stroke Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ischemic Stroke
1.3.3 Hemorrhagic Stroke
1.3.4 Transient Ischemic Attack
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stroke Therapeutics Market Perspective (2017-2028)
2.2 Stroke Therapeutics Growth Trends by Region
2.2.1 Stroke Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Stroke Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Stroke Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Stroke Therapeutics Market Dynamics
2.3.1 Stroke Therapeutics Industry Trends
2.3.2 Stroke Therapeutics Market Drivers
2.3.3 Stroke Therapeutics Market Challenges
2.3.4 Stroke Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Therapeutics Players by Revenue
3.1.1 Global Top Stroke Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Stroke Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stroke Therapeutics Revenue
3.4 Global Stroke Therapeutics Market Concentration Ratio
3.4.1 Global Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Therapeutics Revenue in 2021
3.5 Stroke Therapeutics Key Players Head office and Area Served
3.6 Key Players Stroke Therapeutics Product Solution and Service
3.7 Date of Enter into Stroke Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Therapeutics Breakdown Data by Type
4.1 Global Stroke Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Stroke Therapeutics Forecasted Market Size by Type (2023-2028)
5 Stroke Therapeutics Breakdown Data by Application
5.1 Global Stroke Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Stroke Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Stroke Therapeutics Market Size (2017-2028)
6.2 North America Stroke Therapeutics Market Size by Type
6.2.1 North America Stroke Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Stroke Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Stroke Therapeutics Market Share by Type (2017-2028)
6.3 North America Stroke Therapeutics Market Size by Application
6.3.1 North America Stroke Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Stroke Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Stroke Therapeutics Market Share by Application (2017-2028)
6.4 North America Stroke Therapeutics Market Size by Country
6.4.1 North America Stroke Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Stroke Therapeutics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Stroke Therapeutics Market Size (2017-2028)
7.2 Europe Stroke Therapeutics Market Size by Type
7.2.1 Europe Stroke Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Stroke Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Stroke Therapeutics Market Share by Type (2017-2028)
7.3 Europe Stroke Therapeutics Market Size by Application
7.3.1 Europe Stroke Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Stroke Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Stroke Therapeutics Market Share by Application (2017-2028)
7.4 Europe Stroke Therapeutics Market Size by Country
7.4.1 Europe Stroke Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Stroke Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stroke Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Stroke Therapeutics Market Size by Type
8.2.1 Asia-Pacific Stroke Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Stroke Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Stroke Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Stroke Therapeutics Market Size by Application
8.3.1 Asia-Pacific Stroke Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Stroke Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Stroke Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Stroke Therapeutics Market Size by Region
8.4.1 Asia-Pacific Stroke Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Stroke Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stroke Therapeutics Market Size (2017-2028)
9.2 Latin America Stroke Therapeutics Market Size by Type
9.2.1 Latin America Stroke Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Stroke Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Stroke Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Stroke Therapeutics Market Size by Application
9.3.1 Latin America Stroke Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Stroke Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Stroke Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Stroke Therapeutics Market Size by Country
9.4.1 Latin America Stroke Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Stroke Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Stroke Therapeutics Market Size by Type
10.2.1 Middle East & Africa Stroke Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Stroke Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Stroke Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Stroke Therapeutics Market Size by Application
10.3.1 Middle East & Africa Stroke Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Stroke Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Stroke Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Stroke Therapeutics Market Size by Country
10.4.1 Middle East & Africa Stroke Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Stroke Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Stroke Therapeutics Introduction
11.1.4 Abbott Laboratories Revenue in Stroke Therapeutics Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Cordis
11.2.1 Cordis Company Details
11.2.2 Cordis Business Overview
11.2.3 Cordis Stroke Therapeutics Introduction
11.2.4 Cordis Revenue in Stroke Therapeutics Business (2017-2022)
11.2.5 Cordis Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Stroke Therapeutics Introduction
11.3.4 Boston Scientific Revenue in Stroke Therapeutics Business (2017-2022)
11.3.5 Boston Scientific Recent Developments
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Stroke Therapeutics Introduction
11.4.4 Siemens Revenue in Stroke Therapeutics Business (2017-2022)
11.4.5 Siemens Recent Developments
11.5 Genentech
11.5.1 Genentech Company Details
11.5.2 Genentech Business Overview
11.5.3 Genentech Stroke Therapeutics Introduction
11.5.4 Genentech Revenue in Stroke Therapeutics Business (2017-2022)
11.5.5 Genentech Recent Developments
11.6 Koninklijke Philips
11.6.1 Koninklijke Philips Company Details
11.6.2 Koninklijke Philips Business Overview
11.6.3 Koninklijke Philips Stroke Therapeutics Introduction
11.6.4 Koninklijke Philips Revenue in Stroke Therapeutics Business (2017-2022)
11.6.5 Koninklijke Philips Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Stroke Therapeutics Introduction
11.7.4 Medtronic Revenue in Stroke Therapeutics Business (2017-2022)
11.7.5 Medtronic Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Stroke Therapeutics Introduction
11.8.4 GE Healthcare Revenue in Stroke Therapeutics Business (2017-2022)
11.8.5 GE Healthcare Recent Developments
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Stroke Therapeutics Introduction
11.9.4 Stryker Revenue in Stroke Therapeutics Business (2017-2022)
11.9.5 Stryker Recent Developments
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Stroke Therapeutics Introduction
11.10.4 Merck Revenue in Stroke Therapeutics Business (2017-2022)
11.10.5 Merck Recent Developments
11.11 Zocere, Inc.
11.11.1 Zocere, Inc. Company Details
11.11.2 Zocere, Inc. Business Overview
11.11.3 Zocere, Inc. Stroke Therapeutics Introduction
11.11.4 Zocere, Inc. Revenue in Stroke Therapeutics Business (2017-2022)
11.11.5 Zocere, Inc. Recent Developments
11.12 Acticor Biotech
11.12.1 Acticor Biotech Company Details
11.12.2 Acticor Biotech Business Overview
11.12.3 Acticor Biotech Stroke Therapeutics Introduction
11.12.4 Acticor Biotech Revenue in Stroke Therapeutics Business (2017-2022)
11.12.5 Acticor Biotech Recent Developments
11.13 DiaMedica Therapeutics
11.13.1 DiaMedica Therapeutics Company Details
11.13.2 DiaMedica Therapeutics Business Overview
11.13.3 DiaMedica Therapeutics Stroke Therapeutics Introduction
11.13.4 DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2017-2022)
11.13.5 DiaMedica Therapeutics Recent Developments
11.14 Lumosa Therapeutics
11.14.1 Lumosa Therapeutics Company Details
11.14.2 Lumosa Therapeutics Business Overview
11.14.3 Lumosa Therapeutics Stroke Therapeutics Introduction
11.14.4 Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2017-2022)
11.14.5 Lumosa Therapeutics Recent Developments
11.15 AXONIS Therapeutics , Inc.
11.15.1 AXONIS Therapeutics , Inc. Company Details
11.15.2 AXONIS Therapeutics , Inc. Business Overview
11.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Introduction
11.15.4 AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2017-2022)
11.15.5 AXONIS Therapeutics , Inc. Recent Developments
11.16 NovaGo Therapeutics
11.16.1 NovaGo Therapeutics Company Details
11.16.2 NovaGo Therapeutics Business Overview
11.16.3 NovaGo Therapeutics Stroke Therapeutics Introduction
11.16.4 NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2017-2022)
11.16.5 NovaGo Therapeutics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Stroke Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Stroke Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Stroke Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Stroke Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Stroke Therapeutics Market Share by Region (2017-2022)
Table 9. Global Stroke Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Stroke Therapeutics Market Share by Region (2023-2028)
Table 11. Stroke Therapeutics Market Trends
Table 12. Stroke Therapeutics Market Drivers
Table 13. Stroke Therapeutics Market Challenges
Table 14. Stroke Therapeutics Market Restraints
Table 15. Global Stroke Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Stroke Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top Stroke Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2021)
Table 18. Ranking of Global Top Stroke Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Stroke Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Stroke Therapeutics Product Solution and Service
Table 22. Date of Enter into Stroke Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Stroke Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Stroke Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global Stroke Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Stroke Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global Stroke Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Stroke Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global Stroke Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Stroke Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America Stroke Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Stroke Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Stroke Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Stroke Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Stroke Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Stroke Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Stroke Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Stroke Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Stroke Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Stroke Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Stroke Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Stroke Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Stroke Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Stroke Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Stroke Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Stroke Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Stroke Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Stroke Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Stroke Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Stroke Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Stroke Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Stroke Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Stroke Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Stroke Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Stroke Therapeutics Product
Table 65. Abbott Laboratories Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Abbott Laboratories Recent Developments
Table 67. Cordis Company Details
Table 68. Cordis Business Overview
Table 69. Cordis Stroke Therapeutics Product
Table 70. Cordis Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 71. Cordis Recent Developments
Table 72. Boston Scientific Company Details
Table 73. Boston Scientific Business Overview
Table 74. Boston Scientific Stroke Therapeutics Product
Table 75. Boston Scientific Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Boston Scientific Recent Developments
Table 77. Siemens Company Details
Table 78. Siemens Business Overview
Table 79. Siemens Stroke Therapeutics Product
Table 80. Siemens Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 81. Siemens Recent Developments
Table 82. Genentech Company Details
Table 83. Genentech Business Overview
Table 84. Genentech Stroke Therapeutics Product
Table 85. Genentech Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Genentech Recent Developments
Table 87. Koninklijke Philips Company Details
Table 88. Koninklijke Philips Business Overview
Table 89. Koninklijke Philips Stroke Therapeutics Product
Table 90. Koninklijke Philips Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Koninklijke Philips Recent Developments
Table 92. Medtronic Company Details
Table 93. Medtronic Business Overview
Table 94. Medtronic Stroke Therapeutics Product
Table 95. Medtronic Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Medtronic Recent Developments
Table 97. GE Healthcare Company Details
Table 98. GE Healthcare Business Overview
Table 99. GE Healthcare Stroke Therapeutics Product
Table 100. GE Healthcare Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 101. GE Healthcare Recent Developments
Table 102. Stryker Company Details
Table 103. Stryker Business Overview
Table 104. Stryker Stroke Therapeutics Product
Table 105. Stryker Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 106. Stryker Recent Developments
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Stroke Therapeutics Product
Table 110. Merck Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 111. Merck Recent Developments
Table 112. Zocere, Inc. Company Details
Table 113. Zocere, Inc. Business Overview
Table 114. Zocere, Inc. Stroke Therapeutics Product
Table 115. Zocere, Inc. Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 116. Zocere, Inc. Recent Developments
Table 117. Acticor Biotech Company Details
Table 118. Acticor Biotech Business Overview
Table 119. Acticor Biotech Stroke Therapeutics Product
Table 120. Acticor Biotech Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 121. Acticor Biotech Recent Developments
Table 122. DiaMedica Therapeutics Company Details
Table 123. DiaMedica Therapeutics Business Overview
Table 124. DiaMedica Therapeutics Stroke Therapeutics Product
Table 125. DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 126. DiaMedica Therapeutics Recent Developments
Table 127. Lumosa Therapeutics Company Details
Table 128. Lumosa Therapeutics Business Overview
Table 129. Lumosa Therapeutics Stroke Therapeutics Product
Table 130. Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 131. Lumosa Therapeutics Recent Developments
Table 132. AXONIS Therapeutics , Inc. Company Details
Table 133. AXONIS Therapeutics , Inc. Business Overview
Table 134. AXONIS Therapeutics , Inc. Stroke Therapeutics Product
Table 135. AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 136. AXONIS Therapeutics , Inc. Recent Developments
Table 137. NovaGo Therapeutics Company Details
Table 138. NovaGo Therapeutics Business Overview
Table 139. NovaGo Therapeutics Stroke Therapeutics Product
Table 140. NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2017-2022) & (US$ Million)
Table 141. NovaGo Therapeutics Recent Developments
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stroke Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Intravenous Injection Features
Figure 3. Oral Features
Figure 4. Others Features
Figure 5. Global Stroke Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Ischemic Stroke Case Studies
Figure 7. Hemorrhagic Stroke Case Studies
Figure 8. Transient Ischemic Attack Case Studies
Figure 9. Stroke Therapeutics Report Years Considered
Figure 10. Global Stroke Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Stroke Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Stroke Therapeutics Market Share by Region: 2021 VS 2028
Figure 13. Global Stroke Therapeutics Market Share by Players in 2021
Figure 14. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Stroke Therapeutics Revenue in 2021
Figure 16. North America Stroke Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Stroke Therapeutics Market Size Market Share by Type (2017-2028)
Figure 18. North America Stroke Therapeutics Market Size Market Share by Application (2017-2028)
Figure 19. North America Stroke Therapeutics Market Size Share by Country (2017-2028)
Figure 20. United States Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Stroke Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Stroke Therapeutics Market Size Market Share by Type (2017-2028)
Figure 24. Europe Stroke Therapeutics Market Size Market Share by Application (2017-2028)
Figure 25. Europe Stroke Therapeutics Market Size Share by Country (2017-2028)
Figure 26. Germany Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Stroke Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Stroke Therapeutics Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Stroke Therapeutics Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Stroke Therapeutics Market Size Share by Region (2017-2028)
Figure 36. China Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Stroke Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Stroke Therapeutics Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Stroke Therapeutics Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Stroke Therapeutics Market Size Share by Country (2017-2028)
Figure 46. Mexico Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Stroke Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Stroke Therapeutics Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Stroke Therapeutics Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Stroke Therapeutics Market Size Share by Country (2017-2028)
Figure 52. Turkey Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Stroke Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Abbott Laboratories Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 56. Cordis Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 57. Boston Scientific Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 58. Siemens Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 59. Genentech Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 60. Koninklijke Philips Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 61. Medtronic Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 62. GE Healthcare Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 63. Stryker Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 65. Zocere, Inc. Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 66. Acticor Biotech Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 67. DiaMedica Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 68. Lumosa Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 69. AXONIS Therapeutics , Inc. Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 70. NovaGo Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の4ストロークエンジンオイル市場予測（～2028年）：空冷オイル、液冷オイル The Four-Stroke Engine Oil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界のフィード・エスケープメント市場予測（～2028年）：0.25インチストロークサイズ、0.5インチストロークサイズ、1インチストロークサイズ、2インチストロークサイズ The Feed Escapements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- エクソソーム療法のグローバル市場インサイト・予測（～2028年） Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma. Market Analysis and Insights: Global Exosome Therapy Market The global Exosome Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % dur…
- 副腎白質ジストロフィー治療のグローバル市場インサイト・予測（～2028年） Adrenoleukodystrophy refers to a rare genetic condition that causes the buildup of long chain fatty acids (VLCFAs) in the brain. ALD is led by a mutation in the ABCD1 gene on the X chromosome. The three types of adrenoleukodystrophy including Adrenomyelopathy, Childhood cerebral ALD and Addison’s di…
- カルバペネム系抗生物質のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Carbapenem-Based Antibiotics Market The global Carbapenem-Based Antibiotics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Meropenem ac…